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Because of the high incidence of cardiovascular diseases in Asian countries, traditional fer-
mented foods from Asia have been increasingly investigated for antiatherosclerotic effects.
This study investigated the production of nattokinase, a serine fibrinolytic enzyme, in pigeon
pea by Bacillus subtilis fermentation. B. subtilis 14714, B. subtilis 14715, B. subtilis 14716, and B.
subtilis 14718 were employed to produce nattokinase. The highest nattokinase activity in
pigeon pea was obtained using B. subtilis 14715 fermentation for 32 hours. In addition, the
levels of antioxidants (phenolics and flavonoids) and angiotensin converting enzyme
inhibitory activity were increased in B. subtilis 14715-fermented pigeon pea, compared with
those in nonfermented pigeon pea. In an animalmodel, we found that bothwater extracts of
pigeon pea (100 mg/kg body weight) and water extracts of B. subtilis-fermented pigeon pea
(100 mg/kg body weight) significantly improved systolic blood pressure (21 mmHg) and dia-
stolic blood pressure (30 mmHg) in spontaneously hypertensive rats. These results suggest
that Bacillus-fermented pigeon pea has benefits for cardiovascular health and can be devel-
oped as a new dietary supplement or functional food that prevents hypertension.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.
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Atherosclerosis is the basis of coronary artery disease and one
of the most serious cardiovascular diseases (CVDs) in man.
The chronic injuries of blood vessels that are characteristics ofcinal Plant Development,
g City 813, Taiwan.
d Science, College of Life
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ministration, Taiwan. Publthis disease lead to thrombotic embolism [1]. Consequently, a
great deal of effort has been expended in preventing athero-
sclerosis and the resulting thrombotic diseases [2]. In recent
years, many studies have analyzed the influence of dietary
habits on the generation and mitigation of atherosclerosis [1].Yupintang Traditional Chinese Medicine Foundation, 2F., Number
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traditional fermented foods from Asia have been the subject
of medical research [3]. Thus, it has been suggested that fer-
mented and pickled foods, including fruits, vegetables, and
cereals, may be beneficial for their nutrient contents, such as
minerals, vitamins, dietary fiber, oligosaccharides, phytos-
terols, and antioxidants [4].
During the fermentation of foods, desirable biochemical
changes and significantmodifications in flavor and texture are
brought about through the activity of microorganisms or en-
zymes. For instance, extracts of natto, a traditional foodmade
by the fermentation of cooked soybean by Bacillus subtilis, are
known to consist of nattokinase, a serine fibrinolytic enzyme,
that is secreted from vegetative B. subtilis cells and which has
strong fibrinolytic activity [5]. The in vivo anticoagulant
activity of nattokinase enhances blood circulation by dis-
solving fibrin and soluble fibrin monomers. Because this ki-
nase reduces blood clotting, it helps to prevent CVDs [6].
Recent studies have demonstrated that many of the in-
gredients of natto are useful in the prevention of CVD and
hypertension [7].
Pigeon pea (Cajanus cajan L.) is an important grain legume
crop of rain-field agriculture in the tropics and subtropics.
Pigeon pea is a food that contains high levels of phytosterol,
which has been shown to possess antidyslipidemic activity
[8]. Although utilization of red gram for human nutrition may
be constrained by the presence of protease inhibitors [9], the
extracts of pigeon pea are commonly used to treat diabetes,
febrifuge, dysentery, hepatitis, measles, sickle cell anemia,
and hepatic disorders all over the world [10,11]. Recently, we
have found that pigeon pea may attenuate inflammation and
avoid oxidative damage in RAW264.7 macrophages [12]. The
purpose of this study was to investigate the antihypertensive
properties of nattokinase, angiotensin converting enzyme
inhibition (ACEI) activity, and antioxidative activities from
pigeon pea fermented by B. subtilis.2. Methods
2.1. Bacterial strain and pigeon pea fermentation
Pigeon pea was provided from Taitung District Agricultural
Research and Extension Station of Council of Agriculture
(Taitung, Taiwan). The strains of B. subtilis 14714, B. subtilis
14715, B. subtilis 14716, and B. subtilis 14718 were purchased
from Bioresource Collection and Research Center, Hsinchu,
Taiwan. The strains were cultured in nutrient broth [6] and
incubated at 37C for 24 hours. Each activated culture was
then inoculated into 10 mL of nutrient broth and incubated at
37C for 16 hours. The cultures were subsequently diluted to
108e109 colony forming units/mL and used to inoculate
steamed pigeon pea for fermentation. Briefly, 25 g of pigeon
pea was washed and soaked in distilled water for 18 hours.
After decanting the water, the pigeon pea was placed on a
shelf and steamed at 121C for 30 minutes. The steamed pi-
geon pea was cooled, and inoculated with bacterial inoculum
(2%) and incubated at various temperatures (30C, 35C, 37C,
40C, and 45C) and various relative humidities (75%, 80%,
85%, 90%, and 95%) for various times (8 hours, 16 hours, 24hours, 32 hours, 40 hours, and 48 hours) to evaluate the
optimal conditions for nattokinase and ACEI production. At
the end of fermentation, all samples were freeze-dried (Alpha
1-2/LD-2 freeze-dryer, RZ-5 vacuum pump, Christ, Osterode
am Harz, Germany). Subsequently, the powder of B. subtilis-
fermented pigeon peawas extractedwith distilledwater (1:10/
v:v), and the extract was freeze-dried and stored at 20C.
2.2. Assay for ACEI activity of B. subtilis-fermented
pigeon pea
A 45 mL sample of B. subtilis-fermented pigeon pea extract was
added to 45 mL of ACE (final concentration: 33 mU/mL) previ-
ously dissolved in 0.1M sodium-borate buffer (pH 8.3), and the
mixture was allowed to react for 10 minutes at 37C. Subse-
quently, 45 mL of 3mM N-hippuryl-l-histidyl-l-leucine hydrate
was added and incubated at 37C for 30 minutes, and this
reaction was stopped with 150 mL of 0.1N hydrochloric acid.
Twenty microliters of reacted solution was analyzed using
high-performance liquid chromatography (PU2089 plus, Jasco
Co., Tokyo, Japan). Chromatographic separation was con-
ducted on a C18 column (25 cm  4.6 mm internal diameter,
5 mm, Discovery Bellefonte, PA, USA). An acetonitrile/water
(0:100e70:30with 0.05% trifluoroacetic acid) solutionwas used
as themobile phase, and the flow ratewas 1mL/min. TheACEI
activity was compared with hippuric acid synthesis using an
ultraviolet detector (UV2075 plus, Jasco Co.) [13].
2.3. Assay for nattokinase activity
The nattokinase activity was measured by Japan Bio Science
Laboratory Co. (1997) [14]. Briefly, 1.4 mL of 50mM KCl-H3BO3
buffer and 0.4 mL of 0.72 % of fibrinogen were incubated for 5
minutes at 37C, and then 0.1 mL of thrombin (20 U/mL) was
added to react for 10 minutes at 37C. Subsequently, 0.1 mL of
B. subtilis-fermented pigeon pea extract was added and incu-
bated for 60 minutes at 37C. The reaction was stopped with
2 mL of 0.2M trichloracetate, after centrifuging for 5 minutes
(12,000 rpm). The absorption value was measured at 275 nm.
The activity of nattokinase was calculated using the formula:
Nattokinase activity ¼ ðABASÞ=0:01 1=60 1=0:1D
where AB ¼ absorption value of blank; AS ¼ absorption value
of sample; D ¼ sample dilute.
2.4. Assay for 2,2-diphenyl-1-picrylhydrazyl scavenging
activity
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging
activity was measured using the method described [15].
Briefly, B. subtilis-fermented pigeon pea extracts and DPPH
methanolic solution were mixed and kept in the dark for 60
minutes. The absorbance of the reaction mixture at 517 nm
was measured.
2.5. Assay for reducing power
The reducing power was measured using the approach of Duh
and Yen [16]. B. subtilis-fermented pigeon pea extracts, phos-
phate buffer, and potassium hexacyanoferrate solution were
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acetic acid was added. Following centrifugation at 3000 g for 10
minutes, the supernatant was mixed with distilled water and
ferric chloride, and the reaction was then maintained for 10
minutes. The absorbance at 700 nmwas measured.
2.6. Assay for total antioxidant activity
The antioxidant capacity of B. subtilis-fermented pigeon pea
extracts was measured, using the method of Miller and Rice-
Evans [17]. Peroxidase, hydrogen peroxide, 20-Azinobis [3-
ethylbenzothiazoline-6-sulfonic acid]-diammonium salt
(ABTS), and distilled water were mixed and stored in the dark
for 1 hour at 25C. A sample was subsequently added and the
absorbance at 734 nm was determined.
2.7. Assay for total phenolic acid, flavonoids, and
anthocyanin
The flavonoid contents were determined according to the
modified method [18]. The sample was mixed with water,
aluminium nitrate, and CH3COOH. The mixture was left in a
dark room for 40 minutes and the absorbance was measured
against blank at 415 nm using a spectrophotometer. Quercetin
was used for the standard calibration curve and the flavonoid
contents in the samples were calculated using the linear
equation based on the calibration curve. Phenolic compoundsFig. 1 e Effects of (A) various strains; (B) various temperatures;
activity by Bacillus subtilis-fermented pigeon pea water extracts
(n ¼ 3). CFU ¼ colony forming unit; FU ¼ fibrolytic unit.were estimated using the method described by Singleton and
Rossi [19] with modifications, and gallic acid as a standard
phenolic compound. Briefly, the sample was mixed with Folin
and Ciocalteu's phenol reagent and sodium carbonate solu-
tion (7.5 %) was added and left for 90minutes. The absorbance
wasmeasured at 760 nm. The results were expressed asmg of
gallic acid equivalents/g of extract. Total anthocyanin content
was measured using the pH differential method [20].2.8. Animal experiment and experimental schedule
Male spontaneously hypertensive rats (SHRs, 5 weeks old;
BioLASCO, Taiwan Co., Ltd., Yilan, Taiwan) were housed in
individual plastic cages and subjected to a 12-hour lightedark
cycle with 60% relative humidity at 25 ± 2C. The animals were
given free access to regular rodent chow diet and water for 1
week to adapt to the new environment. The experiments were
carried out in a qualified animal breeding room in the animal
center at our institute (protocol complied with guidelines
described in the “Animal Protection Law”, amended on January
17th, 2001 Hua-Zong-(1)-Yi-Tzi-9000007530, Council of Agri-
culture, Executive Yuan, Taiwan, R.O.C.). The animal study
was approved by the Institutional Animal Care and Use Com-
mittee of National Chiayi University. Animals were randomly
divided into four groups (n ¼ 6), including: (a) hypertensive
SHRs; (b) SHRs þwater extracts of pigeon pea [100 mg/kg body
weight (bw)]; (c) SHRs þ the water extracts of B. subtilis-(C) inoculum; and (D) relative humidity on nattokinase
. Each value represents the mean ± standard deviation
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 7 5 0e7 5 7 753fermented pigeon pea (100mg/kg bw); and (d) SHRsþ captopril
(5 mg/kg bw), an ACE inhibitor. All samples were orally
administered to SHRs for 8 weeks. Blood pressure of SHRs was
measured once every 2-weeks continuously for 8 weeks.
2.9. Blood pressure measurements
After 1 week adaption in the new environment, at 0 hours, 4
hours, 8 hours, and 24 hours after a single oral administration
of samples, individual rats were gently placed in a constant-
temperature holder at 37 ± 1C, and their systolic blood
pressure (SBP) and diastolic blood pressure (DBP) were
measured using tail cuff plethysmography with a photoelec-
tric system (Visitech BP-2000, Napa Place, NC, USA) controlled
with a personal computer. The mean value from at least five
consecutive readingswas used for the calculations. During the
chronic administration, the SBP and DBP were measured
before the weekly administration of samples.
2.10. Statistical analysis
Data were expressed as mean ± standard deviation. Statistical
significancewasdeterminedusingone-wayanalysis of variance
with the general linear model procedure of SPSS Version 17.0
(SPSS Institute, Inc., Chicago, IL, USA), followed by one-way
analysis of variance with Duncan's test.Fig. 2 e Angiotensin-converting-enzyme inhibitory activity
of water extracts from Bacillus subtilis-fermented pigeon
pea. (A) Blank (without treatment with sample); and (B)
treatment with water extracts of B. subtilis-fermented
pigeon pea. Pigeon pea was fermented by B. subtilis 14715
for 32 hours. The EC50 of water extracts of B. subtilis-
fermented pigeon pea on ACEI activity was 1.47 mg/mL.
ACEI ¼ angiotensin converting enzyme inhibition;
HA ¼ hippuric acid; HHL ¼ hippuryl-His-Leu.3. Results and discussion
3.1. Investigation of nattokinase activity
We have shown here that fermentation of pigeon pea by B.
subtilis leads to increased production of nattokinase, which
has been shown to have therapeutic effects in thrombosis. As
shown in Fig. 1, generation of nattokinase was found during
fermentation by various B. subtilis strains, including B. subtilis
14714, B. subtilis 14715, B. subtilis 14716, and B. subtilis 14718.
The greatest nattokinase activity in pigeon peawas fermented
by B. subtilis 14715 for 24 hours to 48 hours (Fig. 1A). For this B.
subtilis strain, the optimal fermentation temperaturewas 35C
for 32 hours (Fig. 1B). An inoculumof 107 colony forming units/
mL of B. subtilis 14715 could obtain the highest nattokinase
activity (48.80 fibrolytic unit/g) after 32 hours fermentation
(Fig. 1C). The optimal relative humidity of 90% yielded a nat-
tokinase activity of 53.03 fibrolytic unit/g after 32 hours
fermentation by B. subtilis 14715 (Fig. 1D).
3.2. ACEI activity of water extracts from B. subtilis-
fermented pigeon pea
Angiotensin stimulates the release of aldosterone in the
rennin-angiotensin system. It increases sodium and water
reabsorption, leads to vasoconstriction, and increases
blood pressure. Its inactive precursor, angiotensinogen, is
converted by renin to inactive angiotensin I, and by ACE to
angiotensin II. Milk is widely considered to be the substrate
for lactic acid bacteria to produce ACE inhibitory peptides.
A number of ACE inhibitory peptides have been shown to be
effective in lowering the blood pressure of SHRs [21]. In thisstudy, we found that B. subtilis 14715 fermentation of pi-
geon pea produced significant ACEI activity for 32 hours,
with an EC50 of 1.47 mg/mL (Fig. 2). However, no such effect
was found in nonfermented pigeon pea (data not shown).3.3. Antioxidant activity of water extracts from B.
subtilis-fermented pigeon pea in vitro
Oxidative damage mediates the pathogenesis of atheroscle-
rosis, a major contributor to CVDs worldwide. Lipid peroxides
have an inhibitory effect on the activity of cholesterol
esterase, an enzyme responsible for plaque formation during
atherosclerosis. Previous studies have indicated that the
modification of diet to include foods that contain antioxidants
might prevent or ameliorate CVDs [22]. The role of oxidative
stress in the pathogenesis of hypertension has been reported
in several studies, and the main mechanism proposed is the
reduced bioavailability of nitric oxide promoting endothelial
dysfunction [23]. Elevated lipid peroxidation byproducts and
decreased activity of antioxidant systems have been reported
in hypertensive patients [23]. Several studies have indicated
Fig. 3 e Effects of water extracts from Bacillus subtilis-fermented pigeon pea on: (A) 2,2-diphenyl-1-picrylhydrazyl
scavenging activity; (B) total antioxidant activity (trolox equivalent antioxidant capacity); and (C) reducing powder. Each
value represents the mean ± standard deviation (n ¼ 3). Pigeon pea was fermented by B. subtilis 14715 for 32 hours.
BHA ¼ butylated hydroxyanisole.
Table 1 e Contents of total phenolics, flavonoids, and
anthocyanin of nonfermented Bascillus subtilis-pigeon
pea and fermented B. subtilis-pigeon pea.
Sample Contentsa
Total phenolic
compounds (mg/g)
Flavonoids
(mg/g)
Anthocyanin
(mg/g)
Nonfermented 10.83 ± 0.63 2.45 ± 1.12 1.05 ± 0.04
Fermentedb 15.15 ± 0.50 5.39 ± 0.76 0.85 ± 0.11
a Values are the mean ± standard deviation (n ¼ 3). Data bearing
different superscript letters in the same column are significantly
different (p < 0.05).
b Pigeon pea was fermented by B. subtilis 14715 for 32 hours.
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 levels in hypertension and have implicated
nicotinamide adenine dinucleotide phosphate-oxidase as a
source of this excess O2
 [24].
We next investigated the antioxidant activity of water ex-
tracts from B. subtilis 14715-fermented pigeon pea. The DPPH-
scavenging activity, total antioxidant activity (trolox-equiva-
lent antioxidant capacity), and reducing power were elevated
in B. subtilis 14715-fermented pigeon pea compared with
nonfermented pigeon pea in a dose-dependent manner
(Fig. 3).
3.4. Antioxidant of water extracts from B. subtilis-
fermented pigeon pea
B. subtilis 14715 fermentation for 32 hours markedly increased
the levels of total phenolic compounds (15.1 mg/g of water
extracts) and flavonoids (5.39mg/g of water extracts), whereas
the anthocyanin level was decreased, compared with non-
fermented pigeon pea (10.8 mg/g of phenolic compounds,
2.4 mg/g of pigeon pea water extracts) (Table 1). These results
suggested that anthocyanin in pigeon pea was converted into
flavonoids by B. subtilis 14715 fermentation.
Not only did we find increased nattokinase activity in
water extracts from B. subtilis 14715-fermented pigeon pea,
but also increased antioxidant capacity and ACEI activity.
These findings suggest that extracts of B. subtilis-fermented
pigeon pea may also have antihypertension potential, in
addition to its antiatherosclerosis potential, and these results
are similar to those found for extracts of natto [25].3.5. Antihypertensive activity of water extracts from
B. subtilis-fermented pigeon pea
Growing evidence suggests that increased oxidative stress is
involved in the pathogenesis of CVD in metabolic syndrome.
Oxidative stress, which may occur as a consequence of the
imbalance between free radical production and the capacity of
cellular antioxidant systems, induces cell damage and the
deregulated production of adipocytokines, which contributes
to obesity-associated insulin resistance and hypertension [26].
Polyphenol-rich food has been reported to show anti-
hypertension effect by ACEI activity in vitro [27]. Antioxidants
also improve endothelium-dependent vasodilatation of
mesenteric arteries in SHRs [26]. Currently, we found that
fermentation of pigeon pea with B. subtilis 14715 increased
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and flavonoids) and ACEI activity, compared with those in
nonfermented pigeon pea extracts. In our in vivo model, the
data showed that the water extracts of B. subtilis-fermented
pigeon pea (100 mg/kg bw) markedly attenuated SBP and DBP
after administration by 21 mmHg and 30 mmHg for 8 hours,
respectively; this effect was greater than the administration of
water extracts of pigeon pea (100mg/kg bw) in SBP and DBP by
9 mmHg and 17 mmHg, respectively. SBP and DBP were both
decreased by 29 mmHg and 36 mmHg in captopril-
administered SHRs (Fig. 4).Fig. 4 e Effect of a single oral administration of pigeon pea
on: (A) systolic blood pressure; and (B) diastolic blood
pressure in spontaneous hypertensive rats (SHRs).
Animals were randomly divided into four groups (n ¼ 6;
significant difference was shown by different letters),
including: hypertensive SHRs; SHRs þ water extracts of
pigeon pea [100mg/kg body weight (bw)]; SHRsþ the water
extracts of Bacillus subtilis-fermented pigeon pea (100 mg/
kg bw); and SHRs þ captopril (5 mg/kg bw). Each value
represents the mean ± standard error of the mean. Both
systolic blood pressure and diastolic blood pressure were
measured after the start (at 6 weeks of age) of chronic
feeding with the water extracts of B. subtilis-fermented
pigeon pea or the water extracts of pigeon pea.
DBP ¼ diastolic blood pressure; SBP ¼ systolic blood
pressure.In addition, Fig. 5 shows changes in the average resting SBP
and DSP throughout the administration period (0e8 weeks).
SBP and DBP were 167 mmHg and 142 mmHg in the water
extracts of B. subtilis-fermented pigeon pea-treated SHRs at
Week 8, respectively, however, SBP and DBP were 183 mmHg
and 166 mmHg in the water extracts of pigeon pea, respec-
tively. These findings indicated that ACEI activity, nattoki-
nase, and antioxidative activities of pigeon pea fermented by
B. subtiliswere able to decrease SBP and DBP, thereby exerting
antihypertension potential, suggesting B. subtilis-fermented
pigeon pea has benefits for cardiovascular health.
Phytochemicals such as resveratrol (30mg/kg bw) has been
reported to attenuate oxidative stress-induced hypertensionFig. 5 e Antihypertensive effects of the water extracts from
Bacillus subtilis-fermented pigeon pea or the water extracts
from pigeon pea. Animals were randomly divided into four
groups (n¼ 6), including: (a) hypertensive spontaneous
hypertensive rats (SHRs); (b) SHRsþwater extracts of pigeon
pea [100 mg/kg body weight (bw)]; (c) SHRsþ the water
extracts of B. subtilis-fermented pigeon pea (100 mg/kg bw);
and (d) SHRsþ captopril (5mg/kg bw). Each value represents
the mean ± standard error of the mean. All samples were
orally administered to SHRs for 8 weeks. Blood pressure of
SHRs wasmeasured once every 2-weeks continuously for 8
weeks. DBP¼ diastolic blood pressure; SBP¼ systolic blood
pressure.
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products have been reported to attenuate hypertension in
recent studies [29,30].Monascus-fermented products have also
been shown to improve hypertension in SHRs, as well as alter
the production of ACEI peptides [31].
Inflammation might contribute to the acceleration of
vascular damage and hypertension and activate the renin-
angiotensin system [32]. Pigeon pea has anti-inflammatory
effects that may contribute to the repression of vascular
inflammation and proinflammatory molecules in the endo-
thelial wall, such as vascular cell adhesion molecule-1, inter-
cellular adhesion molecule, and E-selectin, and these
molecules may lead to hypertension [32]. In a recent study, we
found that pigeon pea was able to inhibit inflammation [12].
Currently, our results also suggest that pigeon pea may pre-
vent hypertension mediated by elevating ACEI activity, nat-
tokinase, and antioxidation in SHRs.4. Conclusion
The beneficial effects of extracts from B. subtilis-fermented
pigeon pea on ACEI activity, antioxidant levels, and nattoki-
nase generation were examined in this study. Extracts from B.
subtilis-fermented pigeon pea significantly elevated antioxi-
dant levels, and raised nattokinase and ACEI activities. These
results suggest that B. subtilis-fermented pigeon pea may be
beneficial to cardiovascular health, and can potentially be
developed as a new dietary supplement or marketed as a
functional food with disease-prevention properties.Conflicts of interest
All contributing authors declare no conflicts of interest.
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